KURE — KraneShares MSCI All China Health Care Index ETF
Data updated: 2026-08-28
KURE — KraneShares MSCI All China Health Care Index ETF. China Mid Cap Blend / Core Health Care Equity. Holdings, fees, performance and SEC filings.
KURE Fund Overview
KURE — KraneShares MSCI All China Health Care Index ETF is a US ETF managed by Krane Shares Trust, categorised as China Mid Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Krane Shares Trust
- Category: China Mid Cap Blend / Core Health Care Equity
- Assets under management: $71.23M
- 1-year return: -3.1%
- Ticker: KURE
- SEC CIK: 0001547576
- SEC series ID: S000059796
- Share class ID: C000195635
KURE Holdings
Top 10 holdings of KraneShares MSCI All China Health Care Index ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| WuXi AppTec Co., Ltd. | 9.14% |
| BeOne Medicines AG | 8.84% |
| Innovent Biologics, Inc. | 8.80% |
| Wuxi Biologics (cayman) Inc. | 7.51% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.59% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.27% |
| Akeso Inc | 3.72% |
| Cspc Pharmaceutical Group Limited | 3.68% |
| Invesco Government & Agency Portfolio | 3.55% |
| Sino Biopharmaceutical Limited | 3.39% |
KURE Portfolio Allocation
Asset-class allocation of KraneShares MSCI All China Health Care Index ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 3.5% |
KURE Performance
Total returns for KURE (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -8.8% |
| 1 year | -3.1% |
| 3 years (annualised) | -2.8% |
| 5 years (annualised) | -16.1% |
KURE Risk Information
Risk metrics for KURE, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 23.3%
KURE Costs and Fees
KURE costs about $65 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.65%
- Gross expense ratio: 0.79%
- Portfolio turnover: 73%
- Brokerage commissions: 9.42 bps of average net assets (SEC N-CEN)
KURE Cashflows
Over the 12 months to 2026-06, KraneShares MSCI All China Health Care Index ETF had net outflows of $15.46M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $0 |
| 2026-05 | −$3.26M |
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | $4.58M |
| 2026-01 | $0 |
KURE Debt Constituents
No individual debt constituents are reported in KraneShares MSCI All China Health Care Index ETF's latest SEC N-PORT filing.
KURE Prospectus and SEC Filings
Official KraneShares MSCI All China Health Care Index ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-07-29
- Prospectus (485BPOS) — filed 2025-07-29
- Prospectus supplement (497) — filed 2026-07-31
- Portfolio holdings (N-PORT) — filed 2026-08-28
- Portfolio holdings (N-PORT) — filed 2026-05-29
- Portfolio holdings (N-PORT) — filed 2026-02-27
- Annual census (N-CEN) — filed 2026-06-15
- Annual census (N-CEN) — filed 2025-06-16
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.